- Home
- Publications
- Publication Search
- Publication Details
Title
Drug safety evaluation of olanzapine pamoate
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 12, Issue 6, Pages 897-903
Publisher
Informa Healthcare
Online
2013-09-12
DOI
10.1517/14740338.2013.832753
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data
- (2012) Holland C Detke et al. BMC Psychiatry
- Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia
- (2012) Michael M. Witte et al. CURRENT MEDICAL RESEARCH AND OPINION
- Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia
- (2011) Angela L Hill et al. BMC Psychiatry
- Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia
- (2011) Haya Ascher-Svanum et al. BMC Psychiatry
- Olanzapine pamoate for the treatment of schizophrenia
- (2011) Dieter Naber EXPERT OPINION ON PHARMACOTHERAPY
- Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials
- (2011) Claudia Leucht et al. SCHIZOPHRENIA RESEARCH
- Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases
- (2010) Holland C Detke et al. BMC Psychiatry
- Olanzapine Long-Acting Injection
- (2010) James E. Frampton DRUGS
- Dose correspondence between olanzapine long-acting injection and oral olanzapine
- (2010) Holland C. Detke et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
- (2010) Rosaria rosaria di lorenzo Neuropsychiatric Disease and Treatment
- Long-acting injectable antipsychotics: focus on olanzapine pamoate
- (2010) Jean-Pierre Lindenmayer Neuropsychiatric Disease and Treatment
- Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia
- (2009) John M. Kane et al. AMERICAN JOURNAL OF PSYCHIATRY
- Second-generation antipsychotic long-acting injections: Systematic review
- (2009) W. Wolfgang Fleischhacker BRITISH JOURNAL OF PSYCHIATRY
- Comparison of treatment completion rates for olanzapine pamoate and risperidone microspheres
- (2009) K. S. Akhras et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia
- (2009) John Lauriello et al. JOURNAL OF CLINICAL PSYCHIATRY
- Psychiatrists’ use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years
- (2009) MX Patel et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Attitudes towards long-acting depot antipsychotics: A survey of patients, relatives and psychiatrists
- (2009) Matthias Jaeger et al. PSYCHIATRY RESEARCH
- Upcoming Agents for the Treatment of Schizophrenia
- (2008) Delia Bishara et al. DRUGS
- Depot and oral antipsychotics: patient preferences and attitudes are not the same thing
- (2008) MX Patel et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Use of Depot Antipsychotic Medications for Medication Nonadherence in Schizophrenia
- (2007) J. C. West et al. SCHIZOPHRENIA BULLETIN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started